2bind Services – Antibody Lead Selection

Antibody Lead Selection: A critical step supported by 2bind's biophysical solutions

In antibody lead selection, evaluating the developability of potential candidates is crucial for advancing promising therapeutic targets. At 2bind, we understand the significance of addressing the complexities inherent in antibody structures and their functional behavior. Our specialized biophysical services are uniquely equipped to assess the developability of antibody leads, providing accurate characterization and enabling informed decision-making in the pursuit of effective therapeutics.

What 2bind can do for your antibody lead selection

Research and planning
Research and planning

Antibody team assembly

Antibody candidates analysis (A priori data analysis, structural analysis, …)

Target analysis (literature research, mechanistical research, etc.)

Selection of suitable technologies for lead ranking

Assay cascade definition

Access and sourcing of material

Assay establishment
Assay establishment

Protein target qualification

Technical lead selection assay establishment

Assay optimization

Assay screening qualification

Antibody lead selection screen
Antibody lead selection screen

Lead candidate ranking via label-free GCI and BLI

Lead candidate ranking via solution-based TRIC (MST) and Spectral Shift

Lead candidate ranking via cell-based Flow Cytometry

Candidate diversification via epitope binning with BLI

Lead candidates characterization
Lead candidates characterization

Antibody characterization via nanoDSF, DLS, HPLC

nanoDSF for conformational stability

DLS for colloidal stability and self-interaction propensity

SEC MALS for size determination and fragmentation, oligomerization and aggregation

HIC for hydrophobic profiling

IEX for charge profiling

Kinetics on live cells with RT-IC

Lead buffer optimization

What 2bind delivers

In advance

During a project

Afterwards

Get In Touch